Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'.
| Image |  |
|---|---|
| Description | scientific article published on 14 March 2018 |
| Author/s |
author: Markus M Lerch Thomas J Ettrich |
| Publication date | March 14, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |